...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Decreased Levels of Blood AMPK alpha 1 but not AMPK alpha 2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study
【24h】

Decreased Levels of Blood AMPK alpha 1 but not AMPK alpha 2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study

机译:血液AMPKα1的水平降低,但在患有轻度认知障碍和Alzheimer疾病的患者中,不是AMPKα2同种型:试点研究

获取原文
获取原文并翻译 | 示例

摘要

Background: There is an urgent need to develop feasible biomarkers for diagnosis and prognosis of Alzheimer's disease (AD). Mounting evidence implicates that dysregulation of energy metabolism is a key and early event in AD pathogenesis. AMP-activated protein kinase (AMPK) is a central molecular sensor that plays a critical role in maintaining cellular energy homeostasis, and aberrant brain AMPK activities are linked to AD pathophysiology.
机译:背景:迫切需要开发可行的生物标志物,用于诊断和预后的阿尔茨海默病(AD)。 安装证据意味着能量新陈代谢的失调是AD发病机制中的关键和早期事件。 AMP-活化的蛋白激酶(AMPK)是一种中央分子传感器,在维持细胞能量稳态中发挥着关键作用,并且异常脑AMPK活性与AD病理生理学相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号